BetaShares Global Healthcare Currency Hedged ETF is a sector & thematic ETF from BetaShares — 66 holdings, with $163.0m under management. 98% of its money is in health care. Its two largest holdings, ELI LILLY & CO and JOHNSON & JOHNSON, make up 16% of the fund. It charges 0.57% a year.
Compare DRUG with another fund →About DRUG
- TypeSector & thematic
- IssuerBetaShares
- Size$163.0m
- Cost0.57% a year
- Holdings66
- Top sectorHealth Care 98%
- Top 2 holdings16%
DRUG rose 0.5% over the last month. On $10,000, that's +$46. NOVOB was the biggest drag at −$34; ABBV helped most at +$57.
What moved it
Gain or loss per $10k invested
- ABBVAbbVie+$57
- ISRGIntuitive+$34
- NOVOBNovo Nordisk−$34
- JNJJ&J−$32
- LLYEli Lilly+$31
- TMOThermo Fisher+$28
- UNHUnitedHealth−$26
- Other 55 holdings−$4
- Other 53 holdings−$6
- UnattributedHedging, fees, timing−$2
- CompoundingDaily returns multiply, they do not add−$5
- Fund return+$46
- Other 2 kinds of news+$5
Each kind of news counts the days those moves happened; No flagged news is every other day. News is tracked for moves large enough to be flagged; most international holdings had none in this range.
All 66 holdings
HideLoading every holding…
Which country
- Other 4 countries−$26
- Other 2 countries−$4